Antiphospholipid syndrome combined with acute coronary syndr
Antiphospholipid syndrome (APS) combined with acute coronary syndrome (ACS) is rarely reported. Published in the journal Medicine, the authors present a case of a male patient with APS was admitted to the hospital, who had recent unstable angina (UA).

The preliminary diagnosis of ACS and UA (BraunwaldiB) was then made. This patient received secondary preventative therapy for coronary heart disease (CHD) in combination with percutaneous transluminal coronary angioplasty (PTCA) and implantation of NeoVas Bioresorbable Coronary Scaffold.

The patient was followed up, without new UA episodes were observed at 6 months, 1 year, and 2 year after surgery, respectively.

The authors concluded that percutaneous coronary intervention (PCI) is effective for APS patients and NeoVas scaffold implantation is presumed safe.

Read in detail here: